A. Caton. n.d. ‘The Branchial Arches and HGF Are Growth-Promoting and Chemoattractant for Cranial Motor Axons’. Development 127 (8): 1751–66. http://dev.biologists.org/content/127/8/1751.long.
A Cruz-Martínez. 2004. ‘Single Fiber Electromyography (SFEMG) in Mitochondrial Diseases (MD)’. Electromyography and Clinical Neurophysiology.
A. M. Gordon. 2000. ‘Regulation of Contraction in Striated Muscle’. Physiological Reviews 80 (2): 853–924. http://physrev.physiology.org/content/80/2/853.long.
Aartsma-Rus, Annemieke. 2012. ‘Overview on AON Design’. In Exon Skipping, edited by Annemieke Aartsma-Rus, vol. 867. Humana Press. https://doi.org/10.1007/978-1-61779-767-5_8.
‘Addgene: CRISPR Guide’. n.d. https://www.addgene.org/crispr/guide/.
Ahmed, Mhoriam, Pedro M. Machado, Adrian Miller, et al. 2016. ‘Targeting Protein Homeostasis in Sporadic Inclusion Body Myositis’. Science Translational Medicine 8 (331): 331ra41-331ra41. https://doi.org/10.1126/scitranslmed.aad4583.
Al-Chalabi, Ammar, Leonard H. van den Berg, and Jan Veldink. 2016. ‘Gene Discovery in Amyotrophic Lateral Sclerosis: Implications for Clinical Management’. Nature Reviews Neurology 13 (2): 96–104. https://doi.org/10.1038/nrneurol.2016.182.
AM Rossor. 2016. ‘Recent Advances in the Genetic Neuropathies’. Current Opinion in Neurology 29 (5). https://doi.org/10.1097/WCO.0000000000000373.
Amato, Anthony A., and Steven A. Greenberg. 2013. ‘Inflammatory Myopathies’. CONTINUUM: Lifelong Learning in Neurology 19 (December): 1615–33. https://doi.org/10.1212/01.CON.0000440662.26427.bd.
Amato, Anthony A., and James A. Russell. 2008. Neuromuscular Disorders. McGraw-Hill.
American Journal of Respiratory and Critical Care Medicine. n.d. http://www.atsjournals.org/doi/abs/10.1164/ajrccm.161.1.9901057.
American Journal of Roentgenology. n.d. http://www.ajronline.org/doi/abs/10.2214/AJR.14.13755.
Andrew G. Engel. 2015. ‘Congenital Myasthenic Syndromes: Pathogenesis, Diagnosis, and Treatment’. The Lancet. Neurology 14 (4). https://doi.org/10.1016/S1474-4422(14)70201-7.
Antoine, Jean-Christophe, and Jean-Philippe Camdessanché. 2013. ‘Paraneoplastic Disorders of the Peripheral Nervous System’. La Presse Médicale 42 (6): e235–44. https://doi.org/10.1016/j.lpm.2013.01.059.
‘APCP’. n.d. http://apcp.csp.org.uk/.
Arthur-Farraj, Peter J., Morwena Latouche, Daniel K. Wilton, et al. 2012. ‘C-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for Regeneration’. Neuron 75 (4): 633–47. https://doi.org/10.1016/j.neuron.2012.06.021.
Auer-Grumbach, Michaela. 2013. ‘Hereditary Sensory and Autonomic Neuropathies’. In Peripheral Nerve Disorders, vol. 115. Elsevier. https://doi.org/10.1016/B978-0-444-52902-2.00050-3.
‘Balance and Walking Involvement in Facioscapulohumeral Dystrophy: A Pilot Study on the Effects of Custom Lower Limb Orthoses - European Journal of Physical and Rehabilitation Medicine 2013 April;49(2):169-78 - Minerva Medica - Journals’. n.d. https://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y2013N02A0169.
Belaya, Katsiaryna, Pedro M. Rodríguez Cruz, Wei Wei Liu, et al. 2015. ‘Mutations in Cause Congenital Myasthenic Syndrome and Bridge Myasthenic Disorders with Dystroglycanopathies’. Brain 138 (9): 2493–504. https://doi.org/10.1093/brain/awv185.
Benson, Michael K. D’A. 2011. Children’s Neuromuscular Disorders. Springer.
Berthelsen, Martin Peter, Edith Husu, Sofie Bouschinger Christensen, Kira Philipsen Prahm, John Vissing, and Bente Rona Jensen. 2014. ‘Anti-Gravity Training Improves Walking Capacity and Postural Balance in Patients with Muscular Dystrophy’. Neuromuscular Disorders 24 (6): 492–98. https://doi.org/10.1016/j.nmd.2014.03.001.
Beryl B. Cummings. 2017. ‘Improving Genetic Diagnosis in Mendelian Disease with Transcriptome Sequencing’. Science Translational Medicine 9 (386). https://doi.org/10.1126/scitranslmed.aal5209.
Best Practice in Memory Services: Learning from across England. n.d. https://www.england.nhs.uk/wp-content/uploads/2014/12/memory-clinics-final.pdf.
Blottner, Dieter, and Michele Salanova. 2015. The Neuromuscular System: From Earth to Space Life Science : Neuromuscular Cell Signalling in Disuse and Exercise. Springer briefs in space life sciences. Springer. http://UCL.eblib.com/patron/FullRecord.aspx?p=1967380.
Boers, M (Boers, M); Brooks, P (Brooks, P); Strand, CV (Strand, CV); Tugwell, P (Tugwell, P). 1998. ‘The OMERACT Filter for Outcome Measures in Rheumatology’. JOURNAL OF RHEUMATOLOGY JOURNAL OF RHEUMATOLOGY 25 (2): 198–99. https://contentstore.cla.co.uk/secure/link?id=caecd7db-09ea-e611-80c9-005056af4099.
Boldrin, Luisa, and Jennifer E Morgan. 2007. ‘Activating Muscle Stem Cells: Therapeutic Potential in Muscle Diseases’. Current Opinion in Neurology 20 (5): 577–82. https://doi.org/10.1097/WCO.0b013e3282ef5919.
Boldrin, Luisa, Peter S. Zammit, and Jennifer E. Morgan. 2015. ‘Satellite Cells from Dystrophic Muscle Retain Regenerative Capacity’. Stem Cell Research 14 (1): 20–29. https://doi.org/10.1016/j.scr.2014.10.007.
Bonanomi, D., and S. L. Pfaff. 2010. ‘Motor Axon Pathfinding’. Cold Spring Harbor Perspectives in Biology 2 (3): a001735–a001735. https://doi.org/10.1101/cshperspect.a001735.
Bönnemann, Carsten G., Ching H. Wang, Susana Quijano-Roy, et al. 2014. ‘Diagnostic Approach to the Congenital Muscular Dystrophies’. Neuromuscular Disorders 24 (4): 289–311. https://doi.org/10.1016/j.nmd.2013.12.011.
Briggs, Deborah, and Jennifer E. Morgan. 2013. ‘Recent Progress in Satellite Cell/Myoblast Engraftment - Relevance for Therapy’. FEBS Journal 280 (17): 4281–93. https://doi.org/10.1111/febs.12273.
Brosius Lutz, Amanda, and Ben A. Barres. 2014. ‘Contrasting the Glial Response to Axon Injury in the Central and Peripheral Nervous Systems’. Developmental Cell 28 (1): 7–17. https://doi.org/10.1016/j.devcel.2013.12.002.
Bushby, Katharine, Richard Finkel, David J Birnkrant, et al. 2010a. ‘Diagnosis and Management of Duchenne Muscular Dystrophy, Part 1: Diagnosis, and Pharmacological and Psychosocial Management’. The Lancet Neurology 9 (1): 77–93. https://doi.org/10.1016/S1474-4422(09)70271-6.
Bushby, Katharine, Richard Finkel, David J Birnkrant, et al. 2010b. ‘Diagnosis and Management of Duchenne Muscular Dystrophy, Part 2: Implementation of Multidisciplinary Care’. The Lancet Neurology 9 (2): 177–89. https://doi.org/10.1016/S1474-4422(09)70272-8.
Bushby, Katharine, Richard Finkel, Brenda Wong, et al. 2014. ‘Ataluren Treatment of Patients with Nonsense Mutation Dystrophinopathy’. Muscle & Nerve 50 (4): 477–87. https://doi.org/10.1002/mus.24332.
By:Hunter, S (Hunter, S); White, M (White, M); Thompson, M (Thompson, M). 1998. ‘Techniques to Evaluate Elderly Human Muscle Function: A Physiological Basis’. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 53 (3). https://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=6&SID=E3HXcKOaUmhvHimfaQi&page=1&doc=1.
Byung-Yong Park. 2010. Induction and Segregation of the Vertebrate Cranial Placodes. https://www.ncbi.nlm.nih.gov/books/NBK53175/.
C F George. 1983. ‘Prescription Information Leaflets: A Pilot Study in General Practice.’ British Medical Journal (Clinical Research Ed.) 287 (6400). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1549423/.
Caballero-Hernandez, Diana, Miguel G. Toscano, Marta Cejudo-Guillen, et al. 2016. ‘The “Omics” of Amyotrophic Lateral Sclerosis’. Trends in Molecular Medicine 22 (1): 53–67. https://doi.org/10.1016/j.molmed.2015.11.001.
Cannon, Stephen C. 2011. ‘Channelopathies of Skeletal Muscle Excitability’. In Comprehensive Physiology, edited by Ronald Terjung. John Wiley & Sons, Inc. https://doi.org/10.1002/cphy.c140062.
Carr, A S, A L Pelayo-Negro, M RB Evans, et al. 2016. ‘A Study of the Neuropathy Associated with Transthyretin Amyloidosis (ATTR) in the UK’. Journal of Neurology, Neurosurgery & Psychiatry 87 (6): 620–27. https://doi.org/10.1136/jnnp-2015-310907.
Carrì, Maria Teresa, Nadia D’Ambrosi, and Mauro Cozzolino. 2017. ‘Pathways to Mitochondrial Dysfunction in ALS Pathogenesis’. Biochemical and Biophysical Research Communications 483 (4): 1187–93. https://doi.org/10.1016/j.bbrc.2016.07.055.
Carstens, P. -O., and J. Schmidt. 2014. ‘Diagnosis, Pathogenesis and Treatment of Myositis: Recent Advances’. Clinical & Experimental Immunology 175 (3): 349–58. https://doi.org/10.1111/cei.12194.
Chhabra, Avneesh. 2014. ‘Peripheral MR Neurography’. Neuroimaging Clinics of North America 24 (1): 79–89. https://doi.org/10.1016/j.nic.2013.03.033.
Cirak, Sebahattin, Virginia Arechavala-Gomeza, Michela Guglieri, et al. 2011. ‘Exon Skipping and Dystrophin Restoration in Patients with Duchenne Muscular Dystrophy after Systemic Phosphorodiamidate Morpholino Oligomer Treatment: An Open-Label, Phase 2, Dose-Escalation Study’. The Lancet 378 (9791): 595–605. https://doi.org/10.1016/S0140-6736(11)60756-3.
Clarke, Charles, Robin Howard, M. Rossor, S. D. Shorvon, National Hospital for Neurology and Neurosurgery (London, England), and Institute of Neurology, Queen Square. 2009. Neurology: A Queen Square Textbook. Wiley-Blackwell. http://onlinelibrary.wiley.com/book/10.1002/9781444311709.
Clarke, Charles, Robin Howard, Martin Rossor, and Simon Shorvon, eds. 2016. Neurology. John Wiley &;#38; Sons, Ltd. https://doi.org/10.1002/9781118486160.
Collins, Michael P., P. James B. Dyck, Gary S. Gronseth, et al. 2010. ‘Peripheral Nerve Society Guideline* on the Classification, Diagnosis, Investigation, and Immunosuppressive Therapy of Non-Systemic Vasculitic Neuropathy: Executive Summary’. Journal of the Peripheral Nervous System 15 (3): 176–84. https://doi.org/10.1111/j.1529-8027.2010.00281.x.
Collins, Michael P., and Robert D. Hadden. 2017. ‘The Nonsystemic Vasculitic Neuropathies’. Nature Reviews Neurology 13 (5): 302–16. https://doi.org/10.1038/nrneurol.2017.42.
Conover, J. C., J. T. Erickson, D.
M. Katz, et al. 1995. ‘Neuronal Deficits, Not Involving Motor Neurons, in Mice Lacking BDNF and/or NT4’. Nature 375 (6528): 235–38. https://doi.org/10.1038/375235a0.
Conwit, Robin A., Minal J. Bhanushali, John D. Porter, Petra Kaufmann, and Laurie Gutmann. 2011. ‘Adding More Muscle and Nerve to Clinical Trials’. Muscle & Nerve 44 (5): 695–702. https://doi.org/10.1002/mus.22130.
Couratier, P., P. Corcia, G. Lautrette, M. Nicol, P.-M. Preux, and B. Marin. 2016. ‘Epidemiology of Amyotrophic Lateral Sclerosis: A Review of Literature’. Revue Neurologique 172 (1): 37–45. https://doi.org/10.1016/j.neurol.2015.11.002.
Craig, Daniel M., Stephen P. Ashcroft, Micah Y. Belew, et al. 2015. ‘Utilizing Small Nutrient Compounds as Enhancers of Exercise-Induced Mitochondrial Biogenesis’. Frontiers in Physiology 6 (October). https://doi.org/10.3389/fphys.2015.00296.
Crisp, Sarah J., Dimitri M. Kullmann, and Angela Vincent. 2016a. ‘Autoimmune Synaptopathies’. Nature Reviews Neuroscience 17 (2): 103–17. https://doi.org/10.1038/nrn.2015.27.
Crisp, Sarah J., Dimitri M. Kullmann, and Angela Vincent. 2016b. ‘Autoimmune Synaptopathies’. Nature Reviews Neuroscience 17 (2): 103–17. https://doi.org/10.1038/nrn.2015.27.
Cruz, Pedro M. Rodríguez, Jacqueline Palace, and David Beeson. 2014. ‘Congenital Myasthenic Syndromes and the Neuromuscular Junction’. Current Opinion in Neurology 27 (5): 566–75. https://doi.org/10.1097/WCO.0000000000000134.
Cup, Edith H., Allan J. Pieterse, Jessica M. ten Broek-Pastoor, et al. 2007. ‘Exercise Therapy and Other Types of Physical Therapy for Patients With Neuromuscular Diseases: A Systematic Review’. Archives of Physical Medicine and Rehabilitation 88 (11): 1452–64. https://doi.org/10.1016/j.apmr.2007.07.024.
Dalakas, Marinos C. 2015. ‘Inflammatory Muscle Diseases’. New England Journal of Medicine 372 (18): 1734–47. https://doi.org/10.1056/NEJMra1402225.
Darabid, Houssam, Anna P. Perez-Gonzalez, and Richard Robitaille. 2014. ‘Neuromuscular Synaptogenesis: Coordinating Partners with Multiple Functions’. Nature Reviews Neuroscience 15 (11): 703–18. https://doi.org/10.1038/nrn3821.
Dasen, Jeremy S., and Thomas M. Jessell. 2009. ‘Chapter Six Hox Networks and the Origins of Motor Neuron Diversity’. In Hox Genes, vol. 88. Elsevier. https://doi.org/10.1016/S0070-2153(09)88006-X.
Davidson, G. L., S. M. Murphy, J. M. Polke, et al. 2012. ‘Frequency of Mutations in the Genes Associated with Hereditary Sensory and Autonomic Neuropathy in a UK Cohort’. Journal of Neurology 259 (8): 1673–85. https://doi.org/10.1007/s00415-011-6397-y.
Davies, A.M. 2013. ‘Regulation of Neuronal Survival by Neurotrophins in the Developing Peripheral Nervous System’. In Patterning and Cell Type Specification in the Developing CNS and PNS. Elsevier. https://doi.org/10.1016/B978-0-12-397265-1.00095-2.
Dimachkie, Mazen M., and Richard J. Barohn. 2013. ‘Guillain-Barré Syndrome and Variants’. Neurologic Clinics 31 (2): 491–510. https://doi.org/10.1016/j.ncl.2013.01.005.
Dubrey, Simon, Elizabeth Ackermann, and Julian Gillmore. 2015. ‘The Transthyretin Amyloidoses: Advances in Therapy’. Postgraduate Medical Journal 91 (1078): 439–48. https://doi.org/10.1136/postgradmedj-2014-133224.
Duncan, John S, Gavin P Winston, Matthias J Koepp, and Sebastien Ourselin. 2016. ‘Brain Imaging in the Assessment for Epilepsy Surgery’. The Lancet Neurology 15 (4): 420–33. https://doi.org/10.1016/S1474-4422(15)00383-X.
Ebens, Allen, Katja Brose, E.David Leonardo, et al. 1996. ‘Hepatocyte Growth Factor/Scatter Factor Is an Axonal Chemoattractant and a Neurotrophic Factor for Spinal Motor Neurons’. Neuron 17 (6): 1157–72. https://doi.org/10.1016/S0896-6273(00)80247-0.
‘Effects of Axon Diameter and Myelination (Video) | Khan Academy’. n.d. https://www.khanacademy.org/science/health-and-medicine/nervous-system-and-sensory-infor/neuron-membrane-potentials-2014-03-27T17:58:17.207Z/v/effects-of-axon-diameter-and-myelination.
Evers, Melvin M., Lodewijk J.A. Toonen, and Willeke M.C. van Roon-Mom. 2015. ‘Antisense Oligonucleotides in Therapy for Neurodegenerative Disorders’. Advanced Drug Delivery Reviews 87 (June): 90–103. https://doi.org/10.1016/j.addr.2015.03.008.
Ferlini, A., C. Scotton, and G. Novelli. 2013. ‘Biomarkers in Rare Diseases’. Public Health Genomics 16 (6): 313–21. https://doi.org/10.1159/000355938.
Fernández, Almudena, Santiago Josa, and Lluis Montoliu. 2017. ‘A History of Genome Editing in Mammals’. Mammalian Genome 28 (7–8): 237–46. https://doi.org/10.1007/s00335-017-9699-2.
Forbes, Sean C., Rebecca J. Willcocks, William T. Triplett, et al. 2014. ‘Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study’. PLoS ONE 9 (9). https://doi.org/10.1371/journal.pone.0106435.
‘Free Guides’. n.d. http://www.plainenglish.co.uk/free-guides.html.
Fuglsang-Frederiksen, Anders. 2006. ‘The Role of Different EMG Methods in Evaluating Myopathy’. Clinical Neurophysiology 117 (6): 1173–89. https://doi.org/10.1016/j.clinph.2005.12.018.
Fuller, Geraint, and Mark Manford. 2010. Neurology: An Illustrated Colour Text. 3rd ed. Churchill Livingstone. https://www.dawsonera.com/guard/protected/dawson.jsp?name=https://shib-idp.ucl.ac.uk/shibboleth&dest=http://www.dawsonera.com/depp/reader/protected/external/AbstractView/S9780702048883.
Gabrielle Natalie Samuel. 2017. ‘The UK’s 100,000 Genomes Project: Manifesting Policymakers’ Expectations’. New Genetics and Society 36 (4). https://doi.org/10.1080/14636778.2017.1370671.
Garner, Mark, Zhenye Ning, and Jill Francis. 2012. ‘A Framework for the Evaluation of Patient Information Leaflets’. Health Expectations 15 (3): 283–94. https://doi.org/10.1111/j.1369-7625.2011.00665.x.
Ghaoui, Roula, Sandra T. Cooper, Monkol Lek, et al. 2015. ‘Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy’. JAMA Neurology 72 (12). https://doi.org/10.1001/jamaneurol.2015.2274.
Gilhus, Nils E. 2016. ‘Myasthenia Gravis’. New England Journal of Medicine 375 (26): 2570–81. https://doi.org/10.1056/NEJMra1602678.
Glover, G. H., and E. Schneider. 1991. ‘Three-Point Dixon Technique for True Water/Fat Decomposition withB0 Inhomogeneity Correction’. Magnetic Resonance in Medicine 18 (2): 371–83. https://doi.org/10.1002/mrm.1910180211.
Goemans, Nathalie M., Mar Tulinius, Johanna T. van den Akker, et al. 2011. ‘Systemic Administration of PRO051 in Duchenne’s Muscular Dystrophy’. New England Journal of Medicine 364 (16): 1513–22. https://doi.org/10.1056/NEJMoa1011367.
Gordon, Elizabeth, Jonathan D. Rohrer, and Nick C. Fox. 2016. ‘Advances in Neuroimaging in Frontotemporal Dementia’. Journal of Neurochemistry 138 (August): 193–210. https://doi.org/10.1111/jnc.13656.
Gordon, Tessa, and Olawale AR Sulaiman. 2012. ‘Nerve Regeneration in the Peripheral Nervous System’. In Neuroglia, edited by Helmut Kettenmann. Oxford University Press. https://doi.org/10.1093/med/9780199794591.003.0055.
Great Britain. Audit Commission for Local Authorities and the National Health Service in England and Wales. n.d. What Seems to Be the Matter Communication (National Health Service Report). Stationery Office. Paperback.
Greenfield, Andy. 2017. ‘Editing Mammalian Genomes: Ethical Considerations’. Mammalian Genome 28 (7–8): 388–93. https://doi.org/10.1007/s00335-017-9702-y.
Griffin, Blanche H, Lyn S Chitty, and Maria Bitner-Glindzicz. 2017. ‘The 100 000 Genomes Project: What It Means for Paediatrics’. Archives of Disease in Childhood - Education & Practice Edition 102 (2): 105–7. https://doi.org/10.1136/archdischild-2016-311029.
‘Guidance for Paediatric Physiotherapists - Managing Neuromuscular Disorders’. n.d. http://apcp.csp.org.uk/publications/guidance-paediatric-physiotherapists-managing-neuromuscular-disorders.
Hardie, D. G. 2006. ‘AMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle’. Physiology 21 (1): 48–60. https://doi.org/10.1152/physiol.00044.2005.
Harland, Richard. 2000. ‘Neural Induction’. Current Opinion in Genetics & Development 10 (4): 357–62. https://doi.org/10.1016/S0959-437X(00)00096-4.
Harridge, S. D. R., R. Bottinelli, M. Canepari, et al. 1996. ‘Whole-Muscle and Single-Fibre Contractile Properties and Myosin Heavy Chain Isoforms in Humans’. Pflügers Archiv - European Journal of Physiology 432 (5): 913–20. https://doi.org/10.1007/s004240050215.
Hawkins, Philip N., Yukio Ando, Angela Dispenzeri, Alejandra Gonzalez-Duarte, David Adams, and Ole B. Suhr. 2015. ‘Evolving Landscape in the Management of Transthyretin Amyloidosis’. Annals of Medicine 47 (8): 625–38. https://doi.org/10.3109/07853890.2015.1068949.
Hawley, John A., Mark Hargreaves, Michael J. Joyner, and Juleen R. Zierath. 2014. ‘Integrative Biology of Exercise’. Cell 159 (4): 738–49. https://doi.org/10.1016/j.cell.2014.10.029.
Hilton-Jones, David, and Martin R. Turner, eds. 2014. Oxford Textbook of Neuromuscular Disorders. Oxford textbooks in clinical neurology. Oxford University Press. http://dx.doi.org/10.1093/med/9780199698073.001.0001.
Hoch, Werner, John McConville, Sigrun Helms, John Newsom-Davis, Arthur Melms, and Angela Vincent. 2001. ‘Auto-Antibodies to the Receptor Tyrosine Kinase MuSK in Patients with Myasthenia Gravis without Acetylcholine Receptor Antibodies’. Nature Medicine 7 (3): 365–68. https://doi.org/10.1038/85520.
Hoffmann, Georg F., Johannes Zschocke, and William L. Nyhan. 2009. Inherited Metabolic Diseases: A Clinical Approach. Springer. http://dx.doi.org/10.1007/978-3-540-74723-9.
Hoier, Birgitte, and Ylva Hellsten. 2014. ‘Exercise-Induced Capillary Growth in Human Skeletal Muscle and the Dynamics of VEGF’. Microcirculation 21 (4): 301–14. https://doi.org/10.1111/micc.12117.
Hollak, Carla E. M., and Robin Lachmann, eds. 2016a. Inherited Metabolic Disease in Adults: A Clinical Guide. Oxford University Press. http://dx.doi.org/10.1093/med/9780199972135.001.0001.
Hollak, Carla E. M., and Robin Lachmann, eds. 2016b. Inherited Metabolic Disease in Adults: A Clinical Guide. Oxford University Press. http://dx.doi.org/10.1093/med/9780199972135.001.0001.
Hollingsworth, Kieren G., Paulo L. de Sousa, Volker Straub, and Pierre G. Carlier. 2012. ‘Towards Harmonization of Protocols for MRI Outcome Measures in Skeletal Muscle Studies: Consensus Recommendations from Two TREAT-NMD NMR Workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris, France’. Neuromuscular Disorders 22 (October): S54–67. https://doi.org/10.1016/j.nmd.2012.06.005.
‘How to Write a Lay Summary | DCC How-to Guides’. n.d. http://www.dcc.ac.uk/resources/how-guides/.
‘How to Write a Lay Summary | Digital Curation Centre’. n.d. http://www.dcc.ac.uk/resources/how-guides/write-lay-summary.
Hull, Jeremy, Roona Aniapravan, Elaine Chan, et al. 2012. ‘British Thoracic Society Guideline for Respiratory Management of Children with Neuromuscular Weakness’. Thorax 67 (Suppl 1): i1–40. https://doi.org/10.1136/thoraxjnl-2012-201964.
Irene Colombo. 2015. ‘Congenital Myopathies: Natural History of a Large Pediatric Cohort’. Neurology 84 (1). https://doi.org/10.1212/WNL.0000000000001110.
Irina Dudanova. 2012. ‘Genetic Evidence for a Contribution of EphA:EphrinA Reverse Signaling to Motor Axon Guidance’. Journal of Neuroscience 32 (15): 5209–15. http://www.jneurosci.org/content/32/15/5209.
Jain, K. K., ed. 2015. Applied Neurogenomics. Neuromethods. Humana Press. http://dx.doi.org/10.1007/978-1-4939-2247-5.
Jean-Yves Hogrel. 2016. ‘Longitudinal Functional and NMR Assessment of Upper Limbs in Duchenne Muscular Dystrophy’. Neurology 86 (11). https://doi.org/10.1212/WNL.0000000000002464.
Jeppesen, T. D., M. Schwartz, D. B. Olsen, et al. 2006. ‘Aerobic Training Is Safe and Improves Exercise Capacity in Patients with Mitochondrial Myopathy’. Brain 129 (12): 3402–12. https://doi.org/10.1093/brain/awl149.
Jessell, Thomas M. 2000. ‘Neuronal Specification in the Spinal Cord: Inductive Signals and Transcriptional Codes’. Nature Reviews Genetics 1 (1): 20–29. https://doi.org/10.1038/35049541.
Jessen, K. R., and R. Mirsky. 2016. ‘The Repair Schwann Cell and Its Function in Regenerating Nerves’. The Journal of Physiology 594 (13): 3521–31. https://doi.org/10.1113/JP270874.
Jessen, Kristjan R., and Rhona Mirsky. 2005. ‘The Origin and Development of Glial Cells in Peripheral Nerves’. Nature Reviews Neuroscience 6 (9): 671–82. https://doi.org/10.1038/nrn1746.
Jessen, Kristján R., Rhona Mirsky, and Alison C. Lloyd. 2015. ‘Schwann Cells: Development and Role in Nerve Repair’. Cold Spring Harbor Perspectives in Biology 7 (7). https://doi.org/10.1101/cshperspect.a020487.
Jones, D. A., Arnold de Haan, and Joan M. Round. 2004. Skeletal Muscle from Molecules to Movement: A Textbook of Muscle Physiology for Sport, Exercise, Physiotherapy and Medicine. Churchill Livingstone.
Kang, Ju-Hee, Magdalena Korecka, Michal J. Figurski, et al. 2015. ‘The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A Review of Progress and Plans’. Alzheimer’s & Dementia 11 (7): 772–91. https://doi.org/10.1016/j.jalz.2015.05.003.
Kanning, Kevin C., Artem Kaplan, and Christopher E. Henderson. 2010. ‘Motor Neuron Diversity in Development and Disease’. Annual Review of Neuroscience 33 (1): 409–40. https://doi.org/10.1146/annurev.neuro.051508.135722.
Kao, Tzu-Jen, Chris Law, and Artur Kania. 2012. ‘Eph and Ephrin Signaling: Lessons Learned from Spinal Motor Neurons’. Seminars in Cell & Developmental Biology 23 (1): 83–91. https://doi.org/10.1016/j.semcdb.2011.10.016.
Karin E. Lundin. 2015. ‘Oligonucleotide Therapies: The Past and the Present’. Human Gene Therapy 26 (8). https://doi.org/10.1089/hum.2015.070.
Keith Baar. 2014. ‘Using Molecular Biology to Maximize Concurrent Training’. Sports Medicine (Auckland, N.z.) 44 (Suppl 2). https://doi.org/10.1007/s40279-014-0252-0.
Kernell, Daniel. 2006. The Motoneurone and Its Muscle Fibres. Oxford University Press. https://doi.org/10.1093/acprof:oso/9780198526551.001.0001.
Khorkova, Olga, and Claes Wahlestedt. 2017. ‘Oligonucleotide Therapies for Disorders of the Nervous System’. Nature Biotechnology 35 (3): 249–63. https://doi.org/10.1038/nbt.3784.
Kimberly Amburgey. 2017. ‘A Natural History Study of X-Linked Myotubular Myopathy’. Neurology 89 (13). https://doi.org/10.1212/WNL.0000000000004415.
Kinali, Maria, Virginia Arechavala-Gomeza, Lucy Feng, et al. 2009. ‘Local Restoration of Dystrophin Expression with the Morpholino Oligomer AVI-4658 in Duchenne Muscular Dystrophy: A Single-Blind, Placebo-Controlled, Dose-Escalation, Proof-of-Concept Study’. The Lancet Neurology 8 (10): 918–28. https://doi.org/10.1016/S1474-4422(09)70211-X.
Koneczny, Inga, Judith Cossins, and Angela Vincent. 2014. ‘The Role of Muscle-Specific Tyrosine Kinase (MuSK) and Mystery of MuSK Myasthenia Gravis’. Journal of Anatomy 224 (1): 29–35. https://doi.org/10.1111/joa.12034.
Koneczny, Inga, Judith Cossins, Patrick Waters, David Beeson, and Angela Vincent. 2013. ‘MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters’. PLoS ONE 8 (11). https://doi.org/10.1371/journal.pone.0080695.
Ladle, David R., Eline Pecho-Vrieseling, and Silvia Arber. 2007. ‘Assembly of Motor Circuits in the Spinal Cord: Driven to Function by Genetic and Experience-Dependent Mechanisms’. Neuron 56 (2): 270–83. https://doi.org/10.1016/j.neuron.2007.09.026.
Leslie Jacobson. 1999. ‘Plasma from Human Mothers of Fetuses with Severe Arthrogryposis Multiplex Congenita Causes Deformities in Mice’. Journal of Clinical Investigation 103 (7). https://doi.org/10.1172/JCI5943.
Li, Lei, Wen-Cheng Xiong, and Lin Mei. 2018. ‘Neuromuscular Junction Formation, Aging, and Disorders’. Annual Review of Physiology 80 (1). https://doi.org/10.1146/annurev-physiol-022516-034255.
Lin, G., D. Mao, and H.J. Bellen. 2017. ‘Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload’. In Fly Models of Human Diseases, vol. 121. Elsevier. https://doi.org/10.1016/bs.ctdb.2016.07.004.
Lu, C.-H., C. Macdonald-Wallis, E. Gray, et al. 2015. ‘Neurofilament Light Chain: A Prognostic Biomarker in Amyotrophic Lateral Sclerosis’. Neurology 84 (22): 2247–57. https://doi.org/10.1212/WNL.0000000000001642.
Machado, Pedro, Stefen Brady, and Michael G. Hanna. 2013. ‘Update in Inclusion Body Myositis’. Current Opinion in Rheumatology 25 (6): 763–71. https://doi.org/10.1097/01.bor.0000434671.77891.9a.
Machado, Pedro M., Mhoriam Ahmed, Stefen Brady, et al. 2014. ‘Ongoing Developments in Sporadic Inclusion Body Myositis’. Current Rheumatology Reports 16 (12). https://doi.org/10.1007/s11926-014-0477-9.
Machado, Pedro M., Mazen M. Dimachkie, and Richard J. Barohn. 2014. ‘Sporadic Inclusion Body Myositis’. Current Opinion in Neurology 27 (5): 591–98. https://doi.org/10.1097/WCO.0000000000000129.
Marie-Christine Birling. 2017. ‘Modeling Human Disease in Rodents by CRISPR/Cas9 Genome Editing’. Mammalian Genome 28 (7). https://doi.org/10.1007/s00335-017-9703-x.
Matthew N Meriggioli. 2009. ‘Autoimmune Myasthenia Gravis: Emerging Clinical and Biological Heterogeneity’. Lancet Neurology 8 (5). https://doi.org/10.1016/S1474-4422(09)70063-8.
Matthews, E., D. Fialho, S. V. Tan, et al. 2010. ‘The Non-Dystrophic Myotonias: Molecular Pathogenesis, Diagnosis and Treatment’. Brain 133 (1): 9–22. https://doi.org/10.1093/brain/awp294.
Mendell, Jerry R., Nathalie Goemans, Linda P. Lowes, et al. 2016. ‘Longitudinal Effect of Eteplirsen versus Historical Control on Ambulation in Duchenne Muscular Dystrophy’. Annals of Neurology 79 (2): 257–71. https://doi.org/10.1002/ana.24555.
Mendell, Jerry R., Louise R. Rodino-Klapac, Zarife Sahenk, et al. 2013. ‘Eteplirsen for the Treatment of Duchenne Muscular Dystrophy’. Annals of Neurology 74 (5): 637–47. https://doi.org/10.1002/ana.23982.
Menezes, Manoj P, and Kathryn N North. 2012. ‘Inherited Neuromuscular Disorders: Pathway to Diagnosis’. Journal of Paediatrics and Child Health 48 (6): 458–65. https://doi.org/10.1111/j.1440-1754.2011.02210.x.
Metzker, Michael L. 2010. ‘Sequencing Technologies — the next Generation’. Nature Reviews Genetics 11 (1): 31–46. https://doi.org/10.1038/nrg2626.
‘MGI-Mouse Genome Informatics -The International Database Resource for the Laboratory Mouse’. n.d. http://www.informatics.jax.org/.
Mhoriam Ahmed. 2016. ‘Targeting Protein Homeostasis in Sporadic Inclusion Body Myositis’. Science Translational Medicine 8 (331). https://doi.org/10.1126/scitranslmed.aad4583.
Michael Benatar. 2016. ‘ALS Biomarkers for Therapy Development: State of the Field & Future Directions’. Muscle & Nerve 53 (2). https://doi.org/10.1002/mus.24979.
Michael P. Wiggs. 2015. ‘Can Endurance Exercise Preconditioning Prevention Disuse Muscle Atrophy?’ Frontiers in Physiology 6. https://doi.org/10.3389/fphys.2015.00063.
Michell, Andrew. 2013. Understanding EMG. Oxford University Press. https://doi.org/10.1093/med/9780199595501.001.0001.
Miguel A Martín. 2014. Glycogen Storage Disease Type V. https://www.ncbi.nlm.nih.gov/books/NBK1344/.
‘Milestones Timeline : Nature Milestones in DNA’. n.d. https://www.nature.com/milestones/miledna/timeline.html.
Monahan, Zachary, Frank Shewmaker, and Udai Bhan Pandey. 2016. ‘Stress Granules at the Intersection of Autophagy and ALS’. Brain Research 1649 (October): 189–200. https://doi.org/10.1016/j.brainres.2016.05.022.
Monk, Kelly R., M. Laura Feltri, and Carla Taveggia. 2015. ‘New Insights on Schwann Cell Development’. Glia 63 (8): 1376–93. https://doi.org/10.1002/glia.22852.
Morgan, Sarah, and Richard W. Orrell. 2016. ‘Pathogenesis of Amyotrophic Lateral Sclerosis’. British Medical Bulletin 119 (1): 87–98. https://doi.org/10.1093/bmb/ldw026.
Morrow, Jasper M, Christopher D J Sinclair, Arne Fischmann, et al. 2016. ‘MRI Biomarker Assessment of Neuromuscular Disease Progression: A Prospective Observational Cohort Study’. The Lancet Neurology 15 (1): 65–77. https://doi.org/10.1016/S1474-4422(15)00242-2.
Motor Neurone Disease: Assessment and Management | Guidance and Guidelines | NICE. n.d. https://www.nice.org.uk/guidance/ng42.
Muntoni, Francesco, Silvia Torelli, and Alessandra Ferlini. 2003. ‘Dystrophin and Mutations: One Gene, Several Proteins, Multiple Phenotypes’. The Lancet Neurology 2 (12): 731–40. https://doi.org/10.1016/S1474-4422(03)00585-4.
‘Muscular Dystrophy UK’. n.d. http://www.musculardystrophyuk.org/.
Nancy D Leslie. 2014. Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. https://www.ncbi.nlm.nih.gov/books/NBK6816/.
Nancy Leslie. 2017. Pompe Disease. https://www.ncbi.nlm.nih.gov/books/NBK1261/.
Needham, Merrilee, and Frank L. Mastaglia. 2016. ‘Sporadic Inclusion Body Myositis: A Review of Recent Clinical Advances and Current Approaches to Diagnosis and Treatment’. Clinical Neurophysiology 127 (3): 1764–73. https://doi.org/10.1016/j.clinph.2015.12.011.
‘Nerve Signaling’. n.d. https://www.nobelprize.org/educational/medicine/nerve_signaling/index.html.
‘Neuromuscular | Department of Neurology’. n.d. https://neuro.wustl.edu/education/fellowships/neuromuscular/.
‘Neuromuscular Disease Centre’. n.d. http://neuromuscular.wustl.edu/.
Nishimune, Hiroshi. 2012. ‘Active Zones of Mammalian Neuromuscular Junctions: Formation, Density, and Aging’. Annals of the New York Academy of Sciences 1274 (1): 24–32. https://doi.org/10.1111/j.1749-6632.2012.06836.x.
Nishimune, Hiroshi, Gregorio Valdez, George Jarad, et al. 2008. ‘Laminins Promote Postsynaptic Maturation by an Autocrine Mechanism at the Neuromuscular Junction’. The Journal of Cell Biology 182 (6): 1201–15. https://doi.org/10.1083/jcb.200805095.
North, Kathryn N., Ching H. Wang, Nigel Clarke, et al. 2014a. ‘Approach to the Diagnosis of Congenital Myopathies’. Neuromuscular Disorders 24 (2): 97–116. https://doi.org/10.1016/j.nmd.2013.11.003.
North, Kathryn N., Ching H. Wang, Nigel Clarke, et al. 2014b. ‘Approach to the Diagnosis of Congenital Myopathies’. Neuromuscular Disorders 24 (2): 97–116. https://doi.org/10.1016/j.nmd.2013.11.003.
Nowell, Mark, Rachel Sparks, Gergely Zombori, et al. 2017. ‘Resection Planning in Extratemporal Epilepsy Surgery Using 3D Multimodality Imaging and Intraoperative MRI’. British Journal of Neurosurgery 31 (4): 468–70. https://doi.org/10.1080/02688697.2016.1265086.
O’Brien, Thomas D., Neil D. Reeves, Vasilios Baltzopoulos, David A. Jones, and Constantinos N. Maganaris. 2010. ‘In Vivo Measurements of Muscle Specific Tension in Adults and Children’. Experimental Physiology 95 (1): 202–10. https://doi.org/10.1113/expphysiol.2009.048967.
O’Connor, Emily, Ana Töpf, René Zahedi, et al. 2018. ‘Clinical and Research Strategies for Limb-Girdle Congenital Myasthenic Syndromes’. Annals of the New York Academy of Sciences, ahead of print, January 5. https://doi.org/10.1111/nyas.13520.
O’Grady, Gina L., Monkol Lek, Shireen R. Lamande, et al. 2016. ‘Diagnosis and Etiology of Congenital Muscular Dystrophy: We Are Halfway There’. Annals of Neurology 80 (1): 101–11. https://doi.org/10.1002/ana.24687.
Olivé, Montse, Rudolf A. Kley, and Lev G. Goldfarb. 2013. ‘Myofibrillar Myopathies’. Current Opinion in Neurology 26 (5): 527–35. https://doi.org/10.1097/WCO.0b013e328364d6b1.
Olpin, Simon Edward, Elaine Murphy, Richard James Kirk, Robert William Taylor, and Rosaline Quinlivan. 2015. ‘The Investigation and Management of Metabolic Myopathies’. Journal of Clinical Pathology 68 (6): 410–17. https://doi.org/10.1136/jclinpath-2014-202808.
‘OMIM - Online Mendelian Inheritance in Man’. n.d. https://www.omim.org/.
Ørngreen, Mette Cathrine, and John Vissing. 2017. ‘Treatment Opportunities in Patients With Metabolic Myopathies’. Current Treatment Options in Neurology 19 (11). https://doi.org/10.1007/s11940-017-0473-2.
Orrell, Richard WBarclay, Chris. n.d. ‘Diagnosis and Management of Motor Neurone Disease’. Practitioner 260: 17–21. https://search.proquest.com/docview/1844334383?OpenUrlRefId=info:xri/sid:primo&accountid=14511.
Otto, Markus, Robert Bowser, Martin Turner, et al. 2012. ‘Roadmap and Standard Operating Procedures for Biobanking and Discovery of Neurochemical Markers in ALS’. Amyotrophic Lateral Sclerosis 13 (1): 1–10. https://doi.org/10.3109/17482968.2011.627589.
Paganoni, Sabrina, and Anthony Amato. 2013. ‘Electrodiagnostic Evaluation of Myopathies’. Physical Medicine and Rehabilitation Clinics of North America 24 (1): 193–207. https://doi.org/10.1016/j.pmr.2012.08.017.
‘Part Two - The Specifics - Access to Understanding’. n.d. http://www.access2understanding.org/guidance/part-two-the-specifics/.
Pasterkamp, R. Jeroen. 2012. ‘Getting Neural Circuits into Shape with Semaphorins’. Nature Reviews Neuroscience 13 (9): 605–18. https://doi.org/10.1038/nrn3302.
Peter S. Zammit. 2004. ‘Muscle Satellite Cells Adopt Divergent Fates: A Mechanism for Self-Renewal?’ The Journal of Cell Biology 166 (3). https://doi.org/10.1083/jcb.200312007.
Plante-Bordeneuve, V., A. Ferreira, T. Lalu, et al. 2007. ‘Diagnostic Pitfalls in Sporadic Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)’. Neurology 69 (7): 693–98. https://doi.org/10.1212/01.wnl.0000267338.45673.f4.
Preston, David C., and Barbara Ellen Shapiro. 2013. Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations. 3rd ed. Elsevier Saunders.
Purves, Dale. 2001. Neuroscience. National Library of Medicine. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=neurosci.TOC&depth=2.
Qualification Process for Drug Development Tools. n.d. https://www.fda.gov/downloads/drugs/guidances/ucm230597.pdf.
Quijano-Roy, Susana, Robert Y. Carlier, and Dirk Fischer. 2011. ‘Muscle Imaging in Congenital Myopathies’. Seminars in Pediatric Neurology 18 (4): 221–29. https://doi.org/10.1016/j.spen.2011.10.003.
R Bottinelli. 1996. ‘Force-Velocity Properties of Human Skeletal Muscle Fibres: Myosin Heavy Chain Isoform and Temperature Dependence.’ The Journal of Physiology 495 (Pt 2). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1160815/.
R Klein. 1994. ‘Role of Neurotrophins in Mouse Neuronal Development.’ The FASEB Journal 8 (10): 738–44. http://www.fasebj.org/content/8/10/738.long.
Ravenscroft, Gianina, Mark R. Davis, Phillipa Lamont, Alistair Forrest, and Nigel G. Laing. 2017. ‘New Era in Genetics of Early-Onset Muscle Disease: Breakthroughs and Challenges’. Seminars in Cell & Developmental Biology 64 (April): 160–70. https://doi.org/10.1016/j.semcdb.2016.08.002.
Ravenscroft, Gianina, Nigel G. Laing, and Carsten G. Bönnemann. 2015. ‘Pathophysiological Concepts in the Congenital Myopathies: Blurring the Boundaries, Sharpening the Focus’. Brain 138 (2): 246–68. https://doi.org/10.1093/brain/awu368.
‘Readable | Free Readability Test Tool’. n.d. https://www.webpagefx.com/tools/read-able/.
Rees, J H. 2004. ‘Paraneoplastic Syndromes: When to Suspect, How to Confirm, and How to Manage’. Journal of Neurology, Neurosurgery & Psychiatry 75 (suppl_2): ii43–50. https://doi.org/10.1136/jnnp.2004.040378.
Reilly, M., and Vera Fridman. 2015. ‘Inherited Neuropathies’. Seminars in Neurology 35 (04): 407–23. https://doi.org/10.1055/s-0035-1558981.
Renton, Alan E, Adriano Chiò, and Bryan J Traynor. 2014. ‘State of Play in Amyotrophic Lateral Sclerosis Genetics’. Nature Neuroscience 17 (1): 17–23. https://doi.org/10.1038/nn.3584.
Richard J. Barohn. 2014. ‘A PATTERN RECOGNITION APPROACH TO THE PATIENT WITH A SUSPECTED MYOPATHY’. Neurologic Clinics 32 (3). https://doi.org/10.1016/j.ncl.2014.04.008.
Richards, Sue, Nazneen Aziz, Sherri Bale, et al. 2015. ‘Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology’. Genetics in Medicine 17 (5): 405–23. https://doi.org/10.1038/gim.2015.30.
Ricotti, V., D. A. Ridout, E. Scott, et al. 2013. ‘Long-Term Benefits and Adverse Effects of Intermittent versus Daily Glucocorticoids in Boys with Duchenne Muscular Dystrophy’. Journal of Neurology, Neurosurgery & Psychiatry 84 (6): 698–705. https://doi.org/10.1136/jnnp-2012-303902.
Robert M. Brownstone. 2010. ‘Spinal Interneurons Providing Input to the Final Common Path during Locomotion’. Progress in Brain Research 187. https://doi.org/10.1016/B978-0-444-53613-6.00006-X.
Rodríguez Cruz, Pedro M., Jacqueline Palace, and David Beeson. 2014. ‘Inherited Disorders of the Neuromuscular Junction: An Update’. Journal of Neurology 261 (11): 2234–43. https://doi.org/10.1007/s00415-014-7520-7.
Rodríguez Cruz, Pedro M., Caroline Sewry, David Beeson, et al. 2014. ‘Congenital Myopathies with Secondary Neuromuscular Transmission Defects; A Case Report and Review of the Literature’. Neuromuscular Disorders 24 (12): 1103–10. https://doi.org/10.1016/j.nmd.2014.07.005.
Ross, Jacob, Abigail Benn, Jacqueline Jonuschies, et al. 2012. ‘Defects in Glycosylation Impair Satellite Stem Cell Function and Niche Composition in the Muscles of the Dystrophic Large Mouse’. STEM CELLS 30 (10): 2330–41. https://doi.org/10.1002/stem.1197.
Rossor, Alexander M, Aisling S Carr, Helen Devine, et al. 2017. ‘Peripheral Neuropathy in Complex Inherited Diseases: An Approach to Diagnosis’. Journal of Neurology, Neurosurgery & Psychiatry 88 (10): 846–63. https://doi.org/10.1136/jnnp-2016-313960.
Rossor, Alexander M, Matthew R B Evans, and Mary M Reilly. 2015a. ‘A Practical Approach to the Genetic Neuropathies’. Practical Neurology 15 (3): 187–98. https://doi.org/10.1136/practneurol-2015-001095.
Rossor, Alexander M, Matthew R B Evans, and Mary M Reilly. 2015b. ‘A Practical Approach to the Genetic Neuropathies’. Practical Neurology 15 (3): 187–98. https://doi.org/10.1136/practneurol-2015-001095.
Rossor, Alexander M, Matthew R B Evans, and Mary M Reilly. 2015c. ‘A Practical Approach to the Genetic Neuropathies’. Practical Neurology 15 (3): 187–98. https://doi.org/10.1136/practneurol-2015-001095.
Rossor, Alexander M, Matthew R B Evans, and Mary M Reilly. 2015d. ‘A Practical Approach to the Genetic Neuropathies’. Practical Neurology 15 (3): 187–98. https://doi.org/10.1136/practneurol-2015-001095.
Rossor, Alexander M, Matthew R B Evans, and Mary M Reilly. 2015e. ‘A Practical Approach to the Genetic Neuropathies’. Practical Neurology 15 (3): 187–98. https://doi.org/10.1136/practneurol-2015-001095.
Rossor, Alexander M, Bernadett Kalmar, Linda Greensmith, and Mary M Reilly. 2012. ‘The Distal Hereditary Motor Neuropathies’. Journal of Neurology, Neurosurgery & Psychiatry 83 (1): 6–14. https://doi.org/10.1136/jnnp-2011-300952.
Rossor, Alexander M, Mary M Reilly, and James N Sleigh. 2018. ‘Antisense Oligonucleotides and Other Genetic Therapies Made Simple’. Practical Neurology, ahead of print, February 17. https://doi.org/10.1136/practneurol-2017-001764.
Rossor, Alexander M., Pedro J. Tomaselli, and Mary M. Reilly. 2016a. ‘Recent Advances in the Genetic Neuropathies’. Current Opinion in Neurology, ahead of print, September. https://doi.org/10.1097/WCO.0000000000000373.
Rossor, Alexander M., Pedro J. Tomaselli, and Mary M. Reilly. 2016b. ‘Recent Advances in the Genetic Neuropathies’. Current Opinion in Neurology, ahead of print, September. https://doi.org/10.1097/WCO.0000000000000373.
Rudolf, Rüdiger, Muzamil Majid Khan, Siegfried Labeit, and Michael R. Deschenes. 2014. ‘Degeneration of Neuromuscular Junction in Age and Dystrophy’. Frontiers in Aging Neuroscience 6 (May). https://doi.org/10.3389/fnagi.2014.00099.
Ruegsegger, Céline, and Smita Saxena. 2016. ‘Proteostasis Impairment in ALS’. Brain Research 1648 (October): 571–79. https://doi.org/10.1016/j.brainres.2016.03.032.
‘Safety and Efficacy of Diaphragm Pacing in Patients with Respiratory Insufficiency Due to Amyotrophic Lateral Sclerosis (DiPALS): A Multicentre, Open-Label, Randomised Controlled Trial’. 2015. The Lancet Neurology 14 (9): 883–92. https://doi.org/10.1016/S1474-4422(15)00152-0.
Salzer, James L. 2015. ‘Schwann Cell Myelination’. Cold Spring Harbor Perspectives in Biology 7 (8). https://doi.org/10.1101/cshperspect.a020529.
Samuel, Gabrielle Natalie, and Bobbie Farsides. 2017. ‘Public Trust and “Ethics Review” as a Commodity: The Case of Genomics England Limited and the UK’s 100,000 Genomes Project’. Medicine, Health Care and Philosophy, ahead of print, October 30. https://doi.org/10.1007/s11019-017-9810-1.
Saudubray, J. M., Matthias R. Baumgartner, and John Walter, eds. 2016. Inborn Metabolic Diseases: Diagnosis and Treatment. 6th edition. Springer.
Schlosser, Gerhard. 2006. ‘Induction and Specification of Cranial Placodes’. Developmental Biology 294 (2): 303–51. https://doi.org/10.1016/j.ydbio.2006.03.009.
Schofield, Deborah, Khurshid Alam, Lyndal Douglas, et al. 2017. ‘Cost-Effectiveness of Massively Parallel Sequencing for Diagnosis of Paediatric Muscle Diseases’. Npj Genomic Medicine 2 (1). https://doi.org/10.1038/s41525-017-0006-7.
Schröder, Rolf, and Benedikt Schoser. 2009. ‘Myofibrillar Myopathies: A Clinical and Myopathological Guide’. Brain Pathology 19 (3): 483–92. https://doi.org/10.1111/j.1750-3639.2009.00289.x.
Shaibani, Aziz. 2014. A Video Atlas of Neuromuscular Disorders. Oxford University Press. https://doi.org/10.1093/med/9780199898152.001.0001.
Sharp, Lydia, and Jaya R. Trivedi. 2014. ‘Treatment and Management of Neuromuscular Channelopathies’. Current Treatment Options in Neurology 16 (10). https://doi.org/10.1007/s11940-014-0313-6.
Simon, Neil G., Martin R. Turner, Steve Vucic, et al. 2014. ‘Quantifying Disease Progression in Amyotrophic Lateral Sclerosis’. Annals of Neurology 76 (5): 643–57. https://doi.org/10.1002/ana.24273.
Singhal, Neha, and Paul T. Martin. 2011. ‘Role of Extracellular Matrix Proteins and Their Receptors in the Development of the Vertebrate Neuromuscular Junction’. Developmental Neurobiology 71 (11): 982–1005. https://doi.org/10.1002/dneu.20953.
Spillane, J., D. J. Beeson, and D. M. Kullmann. 2010. ‘Myasthenia and Related Disorders of the Neuromuscular Junction’. Journal of Neurology, Neurosurgery & Psychiatry 81 (8): 850–57. https://doi.org/10.1136/jnnp.2008.169367.
Strength Training and Aerobic Exercise Training for Muscle Disease - van Der Kooi - 2005 - The Cochrane Library - Wiley Online Library. n.d. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003907.pub2/abstract?systemMessage=Wiley+Online+Library+usage+report+download+page+will+be+unavailable+on+Friday+24th+November+2017+at+21%3A00+EST+%2F+02.00+GMT+%2F+10%3A00+SGT+%28Saturday+25th+Nov+for+SGT+.
Sun, Yu, Claudia A.L. Ruivenkamp, Mariëtte J.V. Hoffer, et al. 2015. ‘Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome?’ Human Mutation 36 (6): 648–55. https://doi.org/10.1002/humu.22783.
Sveen, Marie-Louise, Søren P. Andersen, Lina H. Ingelsrud, et al. 2013. ‘Resistance Training in Patients with Limb-Girdle and Becker Muscular Dystrophies’. Muscle & Nerve 47 (2): 163–69. https://doi.org/10.1002/mus.23491.
T. D. Bunker. 1983. ‘An Information Leaflet for Surgical Patients.’ Annals of The Royal College of Surgeons of England 65 (4). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494353/.
Tan, S. Veronica, Emma Matthews, Melissa Barber, et al. 2011. ‘Refined Exercise Testing Can Aid Dna-Based Diagnosis in Muscle Channelopathies’. Annals of Neurology 69 (2): 328–40. https://doi.org/10.1002/ana.22238.
Taniguchi, Masahiko, Shigeki Yuasa, Hajime Fujisawa, et al. 1997. ‘Disruption of Semaphorin III/D Gene Causes Severe Abnormality in Peripheral Nerve Projection’. Neuron 19 (3): 519–30. https://doi.org/10.1016/S0896-6273(00)80368-2.
Teboul, Lydia, Yann Hérault, Cynthia Smith, and Bruce Whitelaw. 2017. ‘Introduction to Mammalian Genome Special Issue: Genome Editing’. Mammalian Genome 28 (7–8): 235–36. https://doi.org/10.1007/s00335-017-9708-5.
Thiede-Stan, N. K., and M. E. Schwab. 2015. ‘Attractive and Repulsive Factors Act through Multi-Subunit Receptor Complexes to Regulate Nerve Fiber Growth’. Journal of Cell Science 128 (14): 2403–14. https://doi.org/10.1242/jcs.165555.
Thomas Wieser. 2017. Carnitine Palmitoyltransferase II Deficiency. https://www.ncbi.nlm.nih.gov/books/NBK1253/.
Toolkit for Producing Patient Information.Pdf. n.d. https://www.uea.ac.uk/documents/246046/0/Toolkit+for+producing+patient+information.pdf.
‘Top Tips for Writing a Lay Summary | The Academy of Medical Sciences’. n.d. https://acmedsci.ac.uk/more/news/10-tips-for-writing-a-lay-summary.
Ulf Andreasson. 2016. ‘Update on Ultrasensitive Technologies to Facilitate Research on Blood Biomarkers for Central Nervous System Disorders’. Alzheimer’s & Dementia : Diagnosis, Assessment & Disease Monitoring 3. https://doi.org/10.1016/j.dadm.2016.05.005.
Vaithinathan, Asokan G., and Vanitha Asokan. 2017. ‘Public Health and Precision Medicine Share a Goal’. Journal of Evidence-Based Medicine 10 (2): 76–80. https://doi.org/10.1111/jebm.12239.
Vakharia, Vejay N., Rachel Sparks, Aidan G. O’Keeffe, et al. 2017. ‘Accuracy of Intracranial Electrode Placement for Stereoelectroencephalography: A Systematic Review and Meta-Analysis’. Epilepsia 58 (6): 921–32. https://doi.org/10.1111/epi.13713.
Van Battum, Eljo Y, Sara Brignani, and R Jeroen Pasterkamp. 2015. ‘Axon Guidance Proteins in Neurological Disorders’. The Lancet Neurology 14 (5): 532–46. https://doi.org/10.1016/S1474-4422(14)70257-1.
Venance, S. L., S. C. Cannon, D. Fialho, et al. 2006. ‘The Primary Periodic Paralyses: Diagnosis, Pathogenesis and Treatment’. Brain 129 (1): 8–17. https://doi.org/10.1093/brain/awh639.
‘Victorian Department of Health / University of Melbourne’. n.d. https://www2.health.vic.gov.au/.
Viegas, Stuart, Leslie Jacobson, Patrick Waters, et al. 2012. ‘Passive and Active Immunization Models of MuSK-Ab Positive Myasthenia: Electrophysiological Evidence for Pre and Postsynaptic Defects’. Experimental Neurology 234 (2): 506–12. https://doi.org/10.1016/j.expneurol.2012.01.025.
Vincent, Angela. 2002. ‘Timeline: Unravelling the Pathogenesis of Myasthenia Gravis’. Nature Reviews Immunology 2 (10): 797–804. https://doi.org/10.1038/nri916.
Wang, Liang, Rüdiger Klein, Binhai Zheng, and Till Marquardt. 2011. ‘Anatomical Coupling of Sensory and Motor Nerve Trajectory via Axon Tracking’. Neuron 71 (2): 263–77. https://doi.org/10.1016/j.neuron.2011.06.021.
Ward, S. 2005. ‘Randomised Controlled Trial of Non-Invasive Ventilation (NIV) for Nocturnal Hypoventilation in Neuromuscular and Chest Wall Disease Patients with Daytime Normocapnia’. Thorax 60 (12): 1019–24. https://doi.org/10.1136/thx.2004.037424.
Wattjes, Mike P., and Dirk Fischer. 2013. Neuromuscular Imaging. Springer. https://www.dawsonera.com/abstract/9781461465522.
Wattjes, Mike P., Rudolf A. Kley, and Dirk Fischer. 2010. ‘Neuromuscular Imaging in Inherited Muscle Diseases’. European Radiology 20 (10): 2447–60. https://doi.org/10.1007/s00330-010-1799-2.
Welch, Marnie B., and Chad M. Brummett. 2011. ‘Peripheral Nervous SystemAnatomy and Function’. In Neuroscientific Foundations of Anesthesiology, edited by George A. Mashour and Ralph Lydic. Oxford University Press. https://doi.org/10.1093/med/9780195398243.003.0067.
Willcocks, Rebecca J., William D. Rooney, William T. Triplett, et al. 2016. ‘Multicenter Prospective Longitudinal Study of Magnetic Resonance Biomarkers in a Large Duchenne Muscular Dystrophy Cohort’. Annals of Neurology 79 (4): 535–47. https://doi.org/10.1002/ana.24599.
Willison, Hugh J, Bart C Jacobs, and Pieter A van Doorn. 2016. ‘Guillain-Barré Syndrome’. The Lancet 388 (10045): 717–27. https://doi.org/10.1016/S0140-6736(16)00339-1.
Wood, Nicholas. 2012. Neurogenetics. Cambridge University Press. https://doi.org/10.1017/CBO9781139087711.
Woollacott, Ione O. C., and Jonathan D. Rohrer. 2016. ‘The Clinical Spectrum of Sporadic and Familial Forms of Frontotemporal Dementia’. Journal of Neurochemistry 138 (August): 6–31. https://doi.org/10.1111/jnc.13654.
Yang, Yaping, Donna M. Muzny, Jeffrey G. Reid, et al. 2013. ‘Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders’. New England Journal of Medicine 369 (16): 1502–11. https://doi.org/10.1056/NEJMoa1306555.
Yates, M, R A Watts, I M Bajema, et al. 2016. ‘EULAR/ERA-EDTA Recommendations for the Management of ANCA-Associated Vasculitis’. Annals of the Rheumatic Diseases 75 (9): 1583–94. https://doi.org/10.1136/annrheumdis-2016-209133.
